Medication info
Teneligliptin 20 mg (Teneligliptin Hydrochloride Hydrate) Tablets

Teneligliptin 20 mg (Teneligliptin Hydrochloride Hydrate) Tablets

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›25.96mg / 1 tablet
Manufacturer / importer
Kyungdong Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202006180 · Approved 2020.09.04 · Insurance code 648104770

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine, whether used alone or in combination therapy, is 20 mg once daily. It may be taken with or without food. When administered in combination with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. No dose adjustment is required in patients with renal impairment. No dose adjustment is required in patients with mild to moderate hepatic impairment.

Ingredients

Manufacturer
Kyungdong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Abnormal blood sugar control in patients with Type 2 diabetes
View approved original text

This medication is used to help control blood sugar levels in adults with Type 2 diabetes. It can be administered alone in conjunction with diet and exercise therapy or combined with other antidiabetic agents such as Metformin or Sulfonylurea in cases where blood sugar control is difficult. This helps to effectively manage blood sugar and reduce the risk of complications.

How to take

Adult dose

The recommended dose of this medicine, whether used alone or in combination therapy, is 20 mg once daily. It may be taken with or without food. When administered in combination with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. No dose adjustment is required in patients with renal impairment. No dose adjustment is required in patients with mild to moderate hepatic impairment.

Precautions

This medication should not be used in patients with allergies to the active ingredient or other components. It is not appropriate for patients with Type 1 diabetes or those who urgently need blood sugar control due to diabetic ketoacidosis or coma. Patients with severe infections or those undergoing pre- and post-surgery or with severe trauma require insulin treatment and should avoid this medication. Caution is needed for patients with severely impaired liver function as safety is not established. For patients with heart failure, it should be used cautiously in mild to moderate cases and is not recommended for severe heart failure. Patients taking Sulfonylureas or insulin should take care due to the risk of hypoglycemia. Patients who are malnourished, have irregular meals, have engaged in vigorous exercise, or consume excessive alcohol may experience hypoglycemic symptoms. Patients with a history of abdominal surgery or bowel obstruction should also be cautious. Patients with cardiac rhythm abnormalities or risk of QT interval prolongation should avoid administration due to the risk of side effects. If symptoms of acute pancreatitis appear, consult a doctor immediately and discontinue use. This medication may cause side effects such as hypoglycemia, constipation, hepatic dysfunction, interstitial pneumonia, skin rash, and acute pancreatitis; therefore, medical attention is required if any unusual symptoms occur. Particularly, when used with other diabetic medications, the risk of hypoglycemia may increase, and careful monitoring of blood sugar changes is essential. It is advisable for pregnant or nursing women to avoid use, and safety in pediatric patients has not been confirmed. Elderly patients should be monitored closely as physiological function may decline during use. In case of overdose, general treatment may be required along with additional treatment depending on the patient's condition. This medication should be stored out of the reach of children and should not be transferred to other containers. During the use of this medication, patients should fully understand the symptoms of hypoglycemia and how to respond, and be cautious when driving or operating machinery. Additionally, if symptoms such as joint pain or skin blisters occur, consult medical personnel immediately.

Side effects

  • Hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • pemphigus
  • acute pancreatitis
  • dizziness
  • abdominal distension
  • abdominal discomfort
Show 105 more
  • nausea
  • abdominal pain
  • flatulence
  • stomatitis
  • gastric polyp
  • colon polyp
  • duodenal ulcer
  • gastroesophageal reflux disease
  • diarrhea
  • decreased appetite
  • increased amylase
  • increased lipase
  • elevated AST(GOT)
  • elevated ALT(GPT)
  • elevated GGT
  • elevated ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • increased CK(CPK)
  • elevated serum potassium levels
  • lethargy
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • nasopharyngitis
  • foot fracture
  • shingles
  • limb pain
  • upper abdominal pain
  • gastritis
  • headache
  • upper respiratory infection
  • dyspepsia
  • chronic gastritis
  • irritable bowel syndrome
  • viral upper respiratory infection
  • fatigue
  • tremors
  • weakness
  • hunger
  • facial edema
  • nausea
  • cold sweat
  • diabetic retinopathy
  • vision decline
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • decreased neutrophils
  • abnormal blood sugar
  • increased blood sugar
  • increased blood pressure
  • hepatic coma
  • lumbar spinal canal stenosis
  • intervertebral disc protrusion
  • intervertebral disc disorders
  • spinal ligament ossification
  • foraminal stenosis
  • rotator cuff syndrome
  • bladder mass
  • ureterolithiasis
  • urinary stone
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyps
  • gastritis
  • biliary obstruction
  • chronic cholecystitis
  • soft tissue infection
  • pneumonia
  • cataract
  • depression
  • iliac artery stenosis
  • vertigo
  • benign prostatic hyperplasia
  • knee surgery
  • hives
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • coronary artery disease
  • unstable angina
  • angina
  • otalgia
  • vertigo
  • iron deficiency anemia
  • food allergy
  • eyelid damage
  • ligament sprain
  • lip damage
  • contusion

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to protect it from air and moisture, maintaining a safe temperature between 1°C and 30°C. Thus, it is advisable to avoid direct sunlight and not to place it in too hot or too cold areas.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.